AG-024322 is a potent and selective multi-targeted CDK inhibitor with broad spectrum anti-proliferative activity

作者
Cathy C. Zhang,Susan E. Kephart,Indrawan McAlpine,Jim Nonomiya,Joseph R. Higgins,Maria E. Arango,Zhengming Yan,Daniel Knighton,Rose Ann Ferre,Jayashree G. Tikhe,Gennady M. Verkhivker,Meirong Xu,William H. Romines,Cindy L. Palmer,Julie Park,Siegfried Reich,Wes Chong,Lin Li,Gerrit Los,Cristina T. Lewis
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:65: 1045-1045 被引量:8
摘要

4415 Uncontrolled cell proliferation is the hallmark of cancer, and is typically manifested by a de-regulation of the cell-division cycle. Cyclin-dependent-kinases (CDKs) play critical roles in regulating the cell cycle by phosphorylating several cellular proteins. The CDKs are de-regulated and activated in most (if not all) human cancers in a variety of ways, including down-regulation or inactivation of the endogenous CDK inhibitory proteins, overexpression of the essential cyclin subunits of the CDKs, and activating mutations in CDK substrates such as the Retinoblastoma (Rb) protein. The activation of CDKs in tumors highlights these enzymes as important cancer targets for novel therapeutic intervention. An integrated strategy of structure-based drug design and combinatorial chemistry efforts was used to optimize compounds with potent and selective inhibition of the major cell cycle kinases CDK1, CDK2 and CDK4. AG-024322 displays potent inhibition of these CDKs, with Ki’s in the 1-3 nM range and selectivity over a number of other kinases. This potent enzymatic inhibition translates to cellular activity, in that AG-024322 also inhibits Rb phosphorylation in cells. Potent antiproliferative activity was demonstrated in multiple human tumor cell lines, with IC50 values ranging from 30 to 200 nM. As expected for a multi-targeted (pan)-CDK inhibitor, AG-024322 causes arrest at multiple stages of the cell cycle. In addition, AG-024322 is cytotoxic and induces cell death by apoptosis in a time- and dose-dependent manner. These results identify AG-024322 as a potent, multi-targeted CDK inhibitor with broad spectrum anti-proliferative activity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
文静的翠彤完成签到 ,获得积分10
刚刚
万能图书馆的应助被洁净宝莹采纳,获得10
刚刚
INT发布了新的文献求助10
1秒前
麦粑块发布了新的文献求助10
1秒前
2秒前
无极微光的应助被CC采纳,获得20
3秒前
斯文败类的应助被脑花采纳,获得10
3秒前
4秒前
勤恳的板凳完成签到 ,获得积分10
4秒前
科研通AI6.2的应助被lhx采纳,获得10
5秒前
chen完成签到,获得积分10
5秒前
hml123发布了新的文献求助10
5秒前
cdercder的应助被栗子砸采纳,获得10
5秒前
6秒前
bobojiayou完成签到,获得积分10
6秒前
7秒前
知予完成签到 ,获得积分10
8秒前
笑点低的衬衫完成签到,获得积分10
9秒前
9秒前
10秒前
fairytaler的应助被arpege采纳,获得10
11秒前
孙子钊完成签到,获得积分10
12秒前
yuan完成签到 ,获得积分10
12秒前
安静葵阴发布了新的文献求助10
12秒前
yjswjf完成签到,获得积分20
13秒前
Empty发布了新的文献求助10
13秒前
14秒前
爆米花的应助被黑糖话梅采纳,获得10
14秒前
AI发布了新的文献求助10
14秒前
深情安青的应助被张兵采纳,获得10
15秒前
15秒前
李爱国的应助被yebo采纳,获得10
15秒前
15秒前
脑花完成签到,获得积分10
16秒前
万能图书馆的应助被Leon采纳,获得10
17秒前
pepsi191完成签到,获得积分10
17秒前
17秒前
18秒前
Hua发布了新的文献求助10
18秒前
眼睛大的之卉完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183263
求助须知:如何正确求助?哪些是违规求助? 9572532
关于积分的说明 21826339
捐赠科研通 7780187
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558131
邀请新用户注册赠送积分活动 2480239